4-Bromo-2,3-dimethyl-1-isopropoxybenzene, 97%, 500mg

(Z)-5-((Z)-3-chloro-4-((S)-2,3-dihydroxypropoxy)benzylidene)-2-(propylimino)-3-(o-tolyl)thiazolidin-4-one, 98%, 1g

2,5-Dimethyl 3-hydroxythiophene-2,5-dicarboxylate, 97%, 5g

(S)-Benzyl 3-benzylpiperazine-1-carboxylate hydrochloride, 97%, 100mg

3-BOC-9-HYDROXY-3-AZASPIRO[5.5]UNDECANE, 97.0%, 10g

(5-{[(tert-butoxy)carbonyl]amino}pentyl)(diazyn-1-ium-1-yl)azanide, 98%, 25g

1,10-Phenanthroline-4,7-diol, 95.0%, 5g

(2E)-1-(3-bromophenyl)-3-(4-bromophenyl)prop-2-en-1-one, 95.0%, 10g

N,O-Bis(trimethylsilyl)acetamide Kit BSA 1 mL * 8 / Reaction vial, capacity 2 mL * 8>80.0%(GC)1kit

tert-butyl (1R,4S)-2-azabicyclo[2.2.1]heptane-2-carboxylate, 95, 100mg

2-Naphthaleneboronic acid, 97.0%, 5g

4-Amino-5-bromo-2-chloropyrimidine, 95.0%, 10g

1,2,3,4-Tetrahydro-quinoxaline, 98.0%, 10g